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Epidermal filaggrin level is affected by ultraviolet B 
irradiation in animal and experimental models. This 
study examined the effect of ultraviolet B irradiation 
on epidermal filaggrin and natural moisturizing factors 
in vivo in healthy adults (n = 22). Participants were ir-
radiated with 2 minimal erythema doses of ultraviolet 
B on the skin. Biopsies and tape strips were collected 
from skin irradiated 24 and 72 h earlier and from non-
irradiated skin (control). Real-time quantitative PCR 
on skin biopsies showed significantly reduced profilag-
grin mRNA expression 24 h after irradiation (mean re-
lative mRNA expression ± standard deviation: control, 
3.86 ± 2.06 vs. 24 h, 1.52 ± 0.640; p = 0.02; n = 8). Im-
munohistochemistry showed aberrant spatial distribu-
tion of filaggrin protein 72 h after irradiation (n = 3). 
High-pressure liquid chromatography of tape extracts 
showed no change in mean total natural moisturizing 
factor levels after irradiation, but mean trans-urocanic 
acid was significantly reduced, as expected (n = 8). In 
conclusion, erythemal doses of ultraviolet B exert acu-
te effects on profilaggrin mRNA and filaggrin protein in 
human skin in vivo.
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Ultraviolet B (UVB) irradiation of human skin (wave­length 280‒315 nm) induces numerous biological 
reactions. The effects are both local and systemic, and 
vary depending on the dose and type of exposure (1–4). 
Notably, high-dose UVB irradiation can compromise the 
functioning of the skin barrier (5, 6).
Filaggrin is an important skin barrier protein. It is 
formed from processing of profilaggrin encoded by the 
filaggrin gene (FLG). Monomeric filaggrin emerges in 
the transition layer between stratum granulosum and 
stratum corneum (SC). In the SC, it is rapidly degraded 
to “natural moisturizing factors” (NMFs) including 
trans-urocanic acid (trans-UCA), a major UVB photon-
absorbing chromophore. Trans-UCA is converted to its 
cis-isomer upon absorption of UVB radiation. Cis-UCA 
may initiate immunosuppression (7–9).
Approximately 10% of white Europeans are carriers of 
loss-of-function mutations in FLG; this is a strong genetic 
risk factor for development of atopic dermatitis (AD). 
UVB phototherapy is commonly used to treat inflam­
matory skin diseases, including AD. It has been shown 
to restore filaggrin levels in patients with AD after 12 
weeks of treatment (10), but little is known about the 
acute effects of erythemal UVB irradiation on filaggrin. 
It is possible that erythemal doses of UVB irradiation 
suppress expression of profilaggrin mRNA expression 
and filaggrin protein. This has been investigated in animal 
models and in human in vitro models. To our knowledge, 
the present study is the first in vivo study in humans to 
investigate the acute effect of erythemal UVB irradiation 
on filaggrin homeostasis.
MATERIALS AND METHODS
Participants 
Twenty-two healthy volunteers of Northern European descent 
were recruited. Approval of the study was obtained from the local 
ethics committee (entry numbers H-4-2014-037 and H-4-2011-
136). Informed consent was obtained from all participants. All 
participants were 18 years old or over, and none of them had a 
history of skin disease or an atopic disposition. Blood samples 
were collected to determine the presence of the most common 
FLG mutations in Europe (R501X, 2282del4, and R2447X), and 
carriers of any of these mutations were excluded. All blood samp­
les were analysed at the Department of Clinical Biochemistry, 
Herlev and Gentofte Hospital, Hellerup, Denmark. The age and 
sex of participants and number of participants in each sample 
group are shown in Table I.
Ultraviolet exposure
The sources of UVB radiation were 2 Philips TL 20W/12 RS bulbs. 
These emitted a spectrum of 280‒365 nm with a peak emission at 
about 310 nm (and the main part of the energy having wavelengths 
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Table I. Demographics (age and sex) and number of participants 
in each sample group 
Demographics mRNA Immunohistochemistry Tape strips
Age, years, median (range) 23 (21–26) 26 (21–56) 25 (19–47)
Men, n (%) 2 (25) 5 (56) 4 (50)
Sample group
Controls, n 8 9 8
24 h, n 8 9 8
72 h, n 8 3 8
For each analysis the control samples and ultraviolet B irradiated samples were 
from the same volunteer.
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between 280 and 320 nm). The irradiation was performed at a 
distance of 35 cm. Minimal erythema dose (MED) was determined 
for each participant. Subsequently, 2 MEDs of UVB radiation were 
administered twice at separate locations on the lower back. The 
areas of the irradiated spots were 1.0 and 6.0 cm2 (for biopsies 
and tape stripping, respectively).
Biopsy specimens
Three punch biopsies (4-mm diameter) were collected from 14 
volunteers, using local anaesthesia. One biopsy was taken from 
irradiated skin 24 h after exposure, another from irradiated skin 72 
h after exposure, and the last from non-irradiated skin (control). 
Biopsies were either submerged immediately in liquid nitrogen for 
mRNA extraction or fixed in 10% formaldehyde for haematoxylin 
and eosin (H&E) staining and determination of filaggrin expression 
using immunohistochemistry. Some biopsies were used for both 
analyses (n = 3). In these cases, the biopsies were immediately 
divided in 2. One half was submerged in liquid nitrogen and the 
other half was fixed in 10% formaldehyde.
RNA purification and real-time quantitative PCR 
Biopsy specimens from skin irradiated 24 h previously, 72 h 
previously, and from non-irradiated skin were used for mRNA 
extraction. Nucleic acids including total cellular RNA were 
extracted and purified from tissue samples using the GeneJET 
RNA Purification Kit according to the protocol supplied by the 
manufacturer (Thermo Fisher Scientific Biosciences, St Leon-Rot, 
Germany), at the Department of Clinical Biochemistry, Herlev and 
Gentofte Hospital, Denmark.
cDNA synthesis and real-time quantitative PCR (RT qPCR) 
analysis were performed by AROS Applied Biotechnology A/S, 
Aarhus, Denmark. Briefly, first-strand cDNA synthesis was 
undertaken using the High Capacity Reverse Transcriptase Kit 
(Thermo Fisher Scientific Biosciences) using 100 ng total RNA. 
A specific target amplification was performed using a pool of the 2 
PCR assays FLG: Hs00856927_g1 and HPRT1: Hs01003267_m1 
(ThermoFisher Scientific), which were also used in the subsequent 
quantitative PCR. The pre-amplified cDNA and the assays were 
loaded on a 96.96 GE Chip and run under standard conditions on 
the Fluidigm Biomark HD system according to the manufacturer’s 
protocol. Data were analysed using Fluidigm BioMark software 
ver. 4.1.3 with linear (derivative) baseline correction and the user 
(detectors) method for Ct threshold settings. Mean Ct values were 
calculated from the raw data, along with assay standard curve 
linearity and amplification efficiency.
Immunohistochemical staining
Biopsy specimens from skin irradiated 24 h previously, skin ir­
radiated 72 h previously, and non-irradiated skin were included 
in the study.
Immunohistochemical staining was performed as described 
previously in detail (11). Briefly, sections were incubated with a 
primary antibody to filaggrin (clone number 15C10, code number 
NCL-Filaggrin; Novocastra Laboratories Ltd, Newcastle upon 
Tyne, UK) followed by incubation with a secondary antibody 
(kit code K5003; Dako A/S, Glostrup, Denmark) Positive con­
trols (human skin tissue) and negative controls (without primary 
antibody) were included to ensure good antigen retrieval and to 
prevent false positives. The staining pattern was also characterized. 
Also, the intensity of staining was scored as negative, weakly 
positive, moderately positive, or strongly positive. Each specimen 
was scored blind by 2 investigators (SS and LS). Biopsies were 
also stained with H&E.
Tape stripping 
Tape strips of the SC were taken simultaneously from non-
irradiated skin and from skin irradiated 24 and 72 h previously. 
Tape stripping was performed and NMF levels were determined 
according to the method described previously in detail (12). 
Briefly, each tape strip was extracted with 0.5 ml 25% (wt/wt) 
ammonia. The ammonia extract was evaporated and the residue 
dissolved in 500 μl water before analysis by high-pressure liquid 
chromatography. The NMF concentrations were normalized ac­
cording to protein concentration calculated from optical density 
values determined by SquameScan (CuDerm, Dallas, TX, USA).
L-histidine (HIS), pyrrolidone carboxylic acid (PCA), trans­
UCA, and cis-UCA were determined and total NMFs were cal­
culated as the sum. 
Statistical analysis
Statistical analysis was performed with the Wilcoxon matched-
pairs signed-rank test (GraphPad Prism version 6.07; GraphPad 
Software, La Jolla, CA, USA).
RESULTS
Profilaggrin mRNA expression following UVB irradiation
RT qPCR was performed on RNA to determine the level 
of profilaggrin mRNA in the epidermis in UVB-irradiated 
and non­irradiated skin (Fig. 1). RT qPCR analysis sho­
wed a significant decrease in profilaggrin mRNA 24 h 
after irradiation compared with control skin (mean rela­
tive mRNA expression ± standard deviation (SD): control, 
3.86 ± 2.06 vs. 24 h, 1.52 ± 0.640; p = 0.02; n = 8). At 72 h 
after irradiation, mRNA expression was comparable to 
the levels found in control skin. 
Fig. 1. Profilaggrin mRNA expression in skin biopsies taken from 
non-irradiated skin (control) and 24 and 72 h after administration 
of a single dose of 2 minimal erythema doses (n = 8). Data are 
expressed as relative expression of FLG compared with the house keeping 
gene HPRT1. The columns represent mean and the error bars represent 
standard deviation. *p < 0.05.
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Pattern of expression of filaggrin protein following UVB 
irradiation
Twenty-four hours after UVB exposure, irradiated skin 
had several suprabasal sunburn cells, pyknotic nuclei, 
and eosinophilic cytoplasm (n = 9). Seventy-two hours 
after UVB exposure, the sunburn cells had moved up­
wards and were found in conjunction with parakeratosis 
in a layer beneath normal-appearing SC and above a mar­
kedly hyperplastic stratum granulosum (Fig. 2) (n = 3). 
Filaggrin protein was examined in irradiated and non-
irradiated skin using immunohistochemical staining. 
A large degree of inter-individual variation was found 
among the subjects included, as judged by staining in­
tensity and extension of positive staining into the epider­
mis. No change was found in staining pattern or overall 
staining intensity 24 h after UVB irradiation (Fig. 2E). 
In all 3 biopsies taken 72 h after irradiation, 2 filaggrin 
zones were observed: an upper zone located further up 
in the SC compared with non-irradiated skin where the 
filaggrin-positive cells appeared to be less nucleated, and 
a lower zone of filaggrin-positive cells located below the 
layer showing sunburn cells and parakeratosis. In this 
lower zone, the filaggrin-positive cells resembled stratum 
granulosum cells. In addition, the upper filaggrin zone 
appeared thinner (Fig. 2F). 
Total NMF levels and trans-UCA levels following UVB 
irradiation
To investigate whether UVB irradiation could affect 
filaggrin degradation products, we evaluated tape strips 
from non-irradiated and irradiated skin. As expected, 
the mean trans-UCA level was significantly reduced 24 
h after irradiation (control, 0.095 ± 0.029 mmol/g tissue 
vs. 24 h, 0.043 ± 0.014 mmol/g; p < 0.01; n = 8) (Fig. 3A). 
A similar decrease was seen at 72 h after irradiation. 
Correspondingly, cis-UCA was increased at 24 and 72 
h after irradiation (Fig. 3B). There was no difference 
between non-irradiated and irradiated skin in mean total 
NMF (Fig. 3C), mean PCA (Fig. 3D) or mean HIS (Fig. 
3E) levels. 
DISCUSSION
This study showed that profilaggrin mRNA expression 
is transiently reduced when human skin is exposed to 
2 MEDs of UVB irradiation. Furthermore, we found 
distinct morphological changes and aberrant spatial 
distribution of filaggrin protein in the epidermis 72 h 
after exposure. 
In contrast to our results, a recent in vitro study found 
that profilaggrin mRNA expression was increased 24 h 
after narrowband UVB irradiation (13). The inconsis­
tency with our data may be explained by differences in 
study design. Firstly, the UVB dose used in the in vitro 
study was performed with a much lower dose of UVB 
that did not cause sunburn cells. Secondly, that study used 
a human epidermal model based only on keratinocytes. 
Thus, dermis and vasculature were absent and there were 
no immune cells. 
It is likely that profilaggrin mRNA expression is redu­
ced because of DNA damage and inflammation induced 
Fig. 2. Histopathological changes caused by 2 minimal erythema doses (MEDs) of ultraviolet B (UVB) irradiation demonstrated by 
haematoxylin-eosin (H&E) staining and filaggrin immunostaining. (A) Non-irradiated skin showing normal epidermis (H&E staining, magnification 
×200). (B) Skin 24 h after UVB irradiation showing sunburn cells in suprabasal layers (arrow) (H&E staining, magnification ×200) (C) Skin 72 h after UVB 
irradiation showing hyperplasia, parakeratosis (arrow) and sunburn cells (H&E staining, magnification ×200). (D) Non-irradiated skin showing normal 
filaggrin expression (magnification ×200). (E) Skin 24 h after irradiation showing no changes in filaggrin expression (magnification ×200). (F) Skin 72 
h after UVB irradiation showing 2 zones of filaggrin positive cells (arrows) (magnification ×200).
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by the UVB irradiation. Thus, tumour necrosis factor-α, 
which is upregulated as early as 6 h after UVB irradiation 
of human skin (14), inhibits profilaggrin mRNA expres­
sion in primary human keratinocytes in vitro (15) and 
may also contribute to the downregulation of profilaggrin 
mRNA. No other UVB-induced cytokines have been 
investigated in this context, but numerous AD-associated 
cytokines have been shown to downregulate FLG mRNA 
expression and filaggrin protein expression in vitro (16, 
17). We have not validated the stability of the reference 
gene HPRT1 in our experimental setup. HPRT1 has 
shown some instability following UVB irradiation of 
cultured keratinocytes (18). Our data should therefore 
be interpreted with caution. 
Our immunohistochemical staining showed a mar­
kedly altered spatial distribution of filaggrin 72 h after 
irradiation with 2 MEDs of UVB. In vitro and xenograft 
studies have failed to find similar changes (19, 20), but 
our data are in agreement with the results of an in vivo 
study of guinea pig skin (21). The results from the latter 
study also showed 2 filaggrin-positive zones 72 h after 
irradiation with 2 MEDs. The authors mainly focused 
on the impact of chemically induced inflammation on 
filaggrin expression, and the morphology of the UVB-
irradiated skin was not described in detail. However, they 
concluded that UVB induces the keratinocytes to skip the 
granular phase at 24 h after exposure and consequently 
produce a layer of filaggrin-free SC, which we do not 
confirm. Moreover, at 72 h after irradiation we found 
that the lower filaggrin zone was aberrantly present in 
stratum granulosum. 
To our knowledge, no other studies have investigated 
the immediate change in NMF levels after erythemal 
UVB irradiation. NMF levels are dependent on the 
amount of filaggrin protein in the epidermis, the rate 
of filaggrin breakdown, and possibly also the rate of 
desquamation. The isomerization of trans-UCA to cis­
UCA in the present study did not influence the total NMF 
level. The reason that we found no changes in total NMF 
levels at 24 and 72 h after exposure despite decreased 
filaggrin expression was probably caused by the fact 
that the SC samples originated from the upper layers of 
the SC. The layers with reduced levels of filaggrin due 
to UV exposure would need at least 2 weeks to reach 
more superficial SC layers. In vitro human studies and in 
vivo animal studies do not necessarily represent human 
responses in vivo accurately, and our data provide more 
insight into the acute effects of UVB exposure. We used 
MED test to ensure that all participants were exposed to 
equal biological doses of UVB irradiation. This was done 
to achieve maximum comparability between participants 
because administration of the same level of UVB irradia­
tion in joules/cm2 could cause inter-individual differences 
in erythema, inflammation, and tissue damage due to 
individual variation in UVB sensitivity. The presence of 
sunburn cells, the significant decrease in trans-UCA, and 
the presence of erythema of the irradiated skin confirm 
that the UVB irradiation was administered correctly. 
However, only healthy white Northern Europeans were 
included, and our data may not apply to individuals with 
skin conditions or to other ethnic groups. Elucidation 
of the immediate effect of UVB irradiation on filaggrin 
Fig. 3. (A) Mean trans-urocanic acid (UCA), 
(B) mean cis-UCA, (C) mean total natural 
moisturizing factor (NMF) (i.e. L-histidine, 
pyrrolidone carboxylic acid, trans-UCA, and 
cis-UCA), (D) mean  pyrrolidone carboxylic 
acid (PCA), and (E) mean L-histidine (HIS), 
in non-irradiated skin (Control) and 24 h and 
72 h after administration of a single dose of 
two minimal erythema doses (MEDs) (n = 8). 
Error bars represent standard deviation 
(SD). *Significant difference compared 
with controls.
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in the skin and therefore the possible effect on the skin 
barrier is important for our understanding of the risk of 
eczema and flare of eczema. Notably, patients with AD 
with acute skin inflammation often cannot tolerate UVB 
irradiation at the start of treatment and many patients 
with AD complain of worsening of dermatitis following 
start-up of UVB treatment. Furthermore, reduction in 
filaggrin levels and thereby trans-UCA or trans-UCA 
levels directly may lead to increased penetration of UVB 
irradiation (22), which could contribute to a higher risk 
of cancer. Patients with AD often have lower filaggrin 
levels in the skin and possibly an increased risk of basal 
cell carcinoma (23, 24). Furthermore, a small study has 
shown an increased risk of squamous cell carcinoma 
in individuals with homozygous FLG loss-of-function 
mutations (25), but further studies are needed.
In conclusion, we found that UVB irradiation has a 
significant impact on profilaggrin mRNA synthesis in 
human skin in vivo and we have confirmed that, after 
irradiation, there is a distinct alteration in the location 
of filaggrin protein. 
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